Vimarsana
Biggest News Aggregation in the World

Page 4 - Aduhelm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aduhelm Today - Breaking & Trending Today

Social Security COLA Is Forecast Around 3% - The New York Times - Vimarsana News

Social Security COLA Is Forecast Around 3% - The New York Times

Analysts say the 2024 adjustment, which helps older Americans keep up with inflation, won’t be nearly as high as this year’s but will still be significant.

Patients, experts weigh pros and cons of newly-approved Alzheimer's treatment - Vimarsana News

Patients, experts weigh pros and cons of newly-approved Alzheimer's treatment

"The big thing is, if this one is so much better do I want to stop for what [would] probably be a year then just to go back to [being] on that?"

PODCAST: Inside the rapidly expanding field of dementia research - Vimarsana News

PODCAST: Inside the rapidly expanding field of dementia research

One of the most frustrating and scary things about dementia is that we still know breathtakingly little about it. But the medical community in Michigan, as in the rest of the U.S., is currently working at unprecedented speed to change that.

FDA Grants Full Approval to Leqembi: Breakthrough Alzheimer's Drug for Medicare Coverage - Vimarsana News

FDA Grants Full Approval to Leqembi: Breakthrough Alzheimer's Drug for Medicare Coverage

The groundbreaking FDA-approved Alzheimer's drug, Leqembi, now covered by Medicare, offers hope and relief to millions of patients and their families.

Alzheimer's drug Leqembi has full FDA approval now and that means Medicare will pay for it | Health - Vimarsana News

Alzheimer's drug Leqembi has full FDA approval now and that means Medicare will pay for it | Health

U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease. The Food and Drug Administration decision clears the way for

Source: ktbs.com